FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014397725> ?p ?o ?g. }

• W2014397725 endingPage "3634" @default.
• W2014397725 startingPage "3625" @default.
• W2014397725 abstract "The interactions between metastatic breast cancer cells and host cells of osteoclastic lineage in bone microenvironment are essential for osteolysis. In vitro studies to evaluate pharmacological agents are mainly limited to their direct effects on cell lines. To mimic the communication between breast cancer cells and human osteoclasts, a simple and reproducible cellular model was established to evaluate the effects of zoledronate (zoledronic acid, ZOL), a bisphosphonate which exerts antiresorptive properties. Human precursor osteoclasts were cultured on bone-like surfaces in the presence of stimuli (sRANKL, M-CSF) to ensure their activation. Furthermore, immature as well as activated osteoclasts were co-cultured with MDA-MB-231 breast cancer cells. TRAP5b and type I collagen N-terminal telopeptide (NTx) were used as markers. Osteoclasts’ adhesion to bone surface and subsequent bone breakdown were evaluated by studying the expression of cell surface receptors and certain functional matrix macromolecules in the presence of ZOL. ZOL significantly suppresses the precursor osteoclast maturation, even when the activation stimuli (sRANKL and M-SCF) are present. Moreover, it significantly decreases bone osteolysis and activity of MMPs as well as precursor osteoclast maturation by breast cancer cells. Additionally, ZOL inhibits the osteolytic activity of mature osteoclasts and the expression of integrin β3, matrix metalloproteinases and cathepsin K, all implicated in adhesion and bone resorption. ZOL exhibits a beneficial inhibitory effect by restricting activation of osteoclasts, bone particle decomposition and the MMP-related breast cancer osteolysis. The proposed cellular model can be reliably used for enhancing preclinical evaluation of pharmacological agents in metastatic bone disease." @default.
• W2014397725 created "2016-06-24" @default.
• W2014397725 creator A5012410418 @default.
• W2014397725 creator A5028205792 @default.
• W2014397725 creator A5031807322 @default.
• W2014397725 creator A5037481344 @default.
• W2014397725 creator A5041919776 @default.
• W2014397725 creator A5053547225 @default.
• W2014397725 creator A5078469311 @default.
• W2014397725 creator A5086817596 @default.
• W2014397725 date "2013-06-01" @default.
• W2014397725 modified "2023-10-01" @default.
• W2014397725 title "Preclinical evaluation of zoledronate using an in vitro mimetic cellular model for breast cancer metastatic bone disease" @default.
• W2014397725 cites W1656339735 @default.
• W2014397725 cites W1937662086 @default.
• W2014397725 cites W1943317391 @default.
• W2014397725 cites W1967568153 @default.
• W2014397725 cites W1968024679 @default.
• W2014397725 cites W1970970199 @default.
• W2014397725 cites W1973142147 @default.
• W2014397725 cites W1979390430 @default.
• W2014397725 cites W1984823727 @default.
• W2014397725 cites W1987444699 @default.
• W2014397725 cites W2000983409 @default.
• W2014397725 cites W2003657739 @default.
• W2014397725 cites W2006061245 @default.
• W2014397725 cites W2006951696 @default.
• W2014397725 cites W2008985536 @default.
• W2014397725 cites W2012553828 @default.
• W2014397725 cites W2017654113 @default.
• W2014397725 cites W2018602999 @default.
• W2014397725 cites W2021418301 @default.
• W2014397725 cites W2027215054 @default.
• W2014397725 cites W2028756633 @default.
• W2014397725 cites W2036834425 @default.
• W2014397725 cites W2038072225 @default.
• W2014397725 cites W2038995854 @default.
• W2014397725 cites W2041252138 @default.
• W2014397725 cites W2043175126 @default.
• W2014397725 cites W2047161892 @default.
• W2014397725 cites W2050763467 @default.
• W2014397725 cites W2058766023 @default.
• W2014397725 cites W2059180322 @default.
• W2014397725 cites W2059387208 @default.
• W2014397725 cites W2063699543 @default.
• W2014397725 cites W2070381129 @default.
• W2014397725 cites W2073927082 @default.
• W2014397725 cites W2073953419 @default.
• W2014397725 cites W2076760492 @default.
• W2014397725 cites W2077073060 @default.
• W2014397725 cites W2087818844 @default.
• W2014397725 cites W2093164779 @default.
• W2014397725 cites W2103283470 @default.
• W2014397725 cites W2111807012 @default.
• W2014397725 cites W2126438645 @default.
• W2014397725 cites W2134623104 @default.
• W2014397725 cites W2136257629 @default.
• W2014397725 cites W2139347911 @default.
• W2014397725 cites W2139985739 @default.
• W2014397725 cites W2139996507 @default.
• W2014397725 cites W2140035585 @default.
• W2014397725 cites W2150250410 @default.
• W2014397725 cites W2397251969 @default.
• W2014397725 cites W4293247451 @default.
• W2014397725 doi "https://doi.org/10.1016/j.bbagen.2013.01.020" @default.
• W2014397725 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23395844" @default.
• W2014397725 hasPublicationYear "2013" @default.
• W2014397725 type Work @default.
• W2014397725 sameAs 2014397725 @default.
• W2014397725 citedByCount "13" @default.
• W2014397725 countsByYear W20143977252013 @default.
• W2014397725 countsByYear W20143977252014 @default.
• W2014397725 countsByYear W20143977252016 @default.
• W2014397725 countsByYear W20143977252017 @default.
• W2014397725 countsByYear W20143977252018 @default.
• W2014397725 countsByYear W20143977252019 @default.
• W2014397725 countsByYear W20143977252020 @default.
• W2014397725 countsByYear W20143977252021 @default.
• W2014397725 countsByYear W20143977252023 @default.
• W2014397725 crossrefType "journal-article" @default.
• W2014397725 hasAuthorship W2014397725A5012410418 @default.
• W2014397725 hasAuthorship W2014397725A5028205792 @default.
• W2014397725 hasAuthorship W2014397725A5031807322 @default.
• W2014397725 hasAuthorship W2014397725A5037481344 @default.
• W2014397725 hasAuthorship W2014397725A5041919776 @default.
• W2014397725 hasAuthorship W2014397725A5053547225 @default.
• W2014397725 hasAuthorship W2014397725A5078469311 @default.
• W2014397725 hasAuthorship W2014397725A5086817596 @default.
• W2014397725 hasConcept C101990758 @default.
• W2014397725 hasConcept C109523444 @default.
• W2014397725 hasConcept C121608353 @default.
• W2014397725 hasConcept C126322002 @default.
• W2014397725 hasConcept C141071460 @default.
• W2014397725 hasConcept C170493617 @default.
• W2014397725 hasConcept C185592680 @default.
• W2014397725 hasConcept C202751555 @default.
• W2014397725 hasConcept C2775930923 @default.
• W2014397725 hasConcept C2776033226 @default.

• next